Your browser doesn't support javascript.
loading
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival.
Brück, Oscar; Dufva, Olli; Hohtari, Helena; Blom, Sami; Turkki, Riku; Ilander, Mette; Kovanen, Panu; Pallaud, Celine; Ramos, Pedro Marques; Lähteenmäki, Hanna; Välimäki, Katja; El Missiry, Mohamed; Ribeiro, Antonio; Kallioniemi, Olli; Porkka, Kimmo; Pellinen, Teijo; Mustjoki, Satu.
Afiliação
  • Brück O; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Dufva O; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Hohtari H; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
  • Blom S; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Turkki R; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Ilander M; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
  • Kovanen P; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Pallaud C; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Ramos PM; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Lähteenmäki H; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Välimäki K; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • El Missiry M; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Ribeiro A; Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Kallioniemi O; Novartis Pharmaceuticals, Basel, Switzerland.
  • Porkka K; Novartis Pharmaceuticals, Basel, Switzerland.
  • Pellinen T; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Mustjoki S; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
Blood Adv ; 4(2): 274-286, 2020 01 28.
Article em En | MEDLINE | ID: mdl-31968078
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medula Óssea / Receptores de Antígenos de Linfócitos T / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medula Óssea / Receptores de Antígenos de Linfócitos T / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Estados Unidos